Platelet and neutrophil distributions in pump oxygenator circuits: III. Influence of nitric oxide gas infusion

ASAIO Journal

Volumn 42, Issue 5, 1996, Pages

  Sly, M Kurt ^a   Prager, Morton D ^a   Li, Jun ^a   Harris, Frederick B ^a   Shastri, Parag ^a   Bhujle, Rohan ^a   Chao, Robert ^a   Kulkarni, Padmakar V ^a   Constantinescu, Anca ^a   Jessen, Michael E ^a   Eberhart, Robert C ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS; ENZYMES; FLOW OF FLUIDS; IMAGING TECHNIQUES; NITROGEN OXIDES; PRESSURE; SURGERY;

CARDIOPULMONARY BYPASS; GAMMA SCINTIGRAPHY; HEMATOCRIT; NEUTROPHIL; NITRIC OXIDE; PLATELETS;

OXYGENATORS;

LEUKOCYTE IN 111; NITRIC OXIDE; THROMBOCYTE IN 111;

ANIMAL CELL; ANIMAL EXPERIMENT; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; GAMMA SCINTIGRAPHY; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; OXYGENATOR; REVIEW; SWINE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 10244278014     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199609000-00036     Document Type: Review

References (16)

1. Bick RL: Alterations of hemostasis associated with cardiopulmonary bypass: pathophysiology, prevention, diagnosis, and management. Semin Thromb Haemostas 3: 59-82, 1976.
2. Collins JD, Bassendine MF, Ferner R, et al: Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 1: 1119-1122, 1983.
3. Baxter P, Rigby ML, Jones OD, Lincoln C, Shinebourne EA: Acute renal failure following cardiopulmonary bypass in children: results of treatment. Int J Cardiol 7: 235-243, 1985.
4. Wilson JW: Pulmonary morphologic changes due to extracorporeal circulation: a model for 'the shock lung' at cellular level in humans, in Forscher BK, Lillehei RC, and Stubbs SS (eds), Shock in Low- and High-Flow states: Proceedings of a Symposium at Brook Lodge, Augusta, Michigan, USA, Amsterdam, Excerpta Medica, 1972, pp. 160-171.
5. Jessen M, Kulkarni P, Constantinescu A, Eberhart R, Li J: Influence of blood flow and surface characteristics on cell adhesion on membrane oxygenator circuit surfaces (Abstract). ASAIO J 41 (Suppl); 63, 1995.
6. Sly MK, Prager MD, Eberhart RC, Jessen ME, Kulkarni PV: Inhibition of surface-induced platelet activation by nitric oxide. ASAIO J 41: M394-M398, 1995.
7. Sly MK: Inhibition of Platelet Activation by Foreign Surfaces with Nitric Oxide Cas. Doctoral dissertation. The University of Texas Southwestern Medical Center at Dallas, Dallas, 1996, pp 55-61.
8. Katsuki S, Arnold W, Mittal C, Murad F: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3: 23-35, 1977.
9. 111-labeled human platelets: improved method, efficacy and evaluation. J Nucl Med 22: 381-385, 1981.
10. Kelm M, Schrader J: Control of coronary vascular tone by nitric oxide. Circ Res 66: 1561-1575, 1990.
11. Doyle MP, Hoekstra JW: Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem 14: 351-358, 1981.
12. Andersson TLC, Vinge E: Interactions between isoprenaline, sodium nitroprusside and isozyme-selective phosphodiesterase inhibitors on ADP-induced platelet aggregation and cyclic nucleotide levels in human platelets. J Cardiovasc Pharmacol 18: 237-242, 1991.
13. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987.
14. Fanta CH: Symptoms and signs of respiratory disorders, in May HL, Aghababian RV, and Fleisher GR (eds), Emergency Medicine, Boston, Little, Brown and Company, 1992, pp. 118-132.
15. Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11: 150-155, 1990.
16. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ: Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946-955, 1981.